Plain-English translation of NCT07339267 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called in Chinese men who have advanced prostate cancer that has spread to other parts of the body. The medication will be given as an injection into the muscle, along with medications you may already be taking for your prostate cancer. The main goals are to see how safe this medication is and how your body processes it.
Advanced prostate cancer that resists standard hormone treatments remains a serious challenge, and doctors need new options to help men live longer and better. This study is exploring whether this medication can help when added to existing treatments that are already part of standard care.
You likely qualify if…
You likely don't qualify if…
You will receive an injection of the new medication once every 12 weeks into the muscle at your hip, along with your regular prostate cancer medications. You will continue this treatment until your cancer progresses or your doctor decides it's best to stop. The study will track how the medication moves through your body and watch carefully for any side effects or safety concerns.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China